Authors
Loading...
Randomized trial evaluates interferon-related gene expression as a biomarker for disease activity in juvenile dermatomyositis, suggesting its clinical utility.
Codes-Méndez et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: